ATE57472T1 - Verfahren zum loesen von wirksubstanzen und auf diese weise erhaltene arzneimittel. - Google Patents

Verfahren zum loesen von wirksubstanzen und auf diese weise erhaltene arzneimittel.

Info

Publication number
ATE57472T1
ATE57472T1 AT85901459T AT85901459T ATE57472T1 AT E57472 T1 ATE57472 T1 AT E57472T1 AT 85901459 T AT85901459 T AT 85901459T AT 85901459 T AT85901459 T AT 85901459T AT E57472 T1 ATE57472 T1 AT E57472T1
Authority
AT
Austria
Prior art keywords
processes
way
active substances
dissolving active
drugs obtained
Prior art date
Application number
AT85901459T
Other languages
English (en)
Inventor
Jerome Corbiere
Original Assignee
Jerome Corbiere
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jerome Corbiere filed Critical Jerome Corbiere
Application granted granted Critical
Publication of ATE57472T1 publication Critical patent/ATE57472T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Indole Compounds (AREA)
AT85901459T 1984-03-14 1985-03-12 Verfahren zum loesen von wirksubstanzen und auf diese weise erhaltene arzneimittel. ATE57472T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH127984 1984-03-14
PCT/FR1985/000050 WO1985004106A1 (fr) 1984-03-14 1985-03-12 Ppocede de solubilisation de principes actifs et compositions pharmaceutiques ainsi obtenues
EP85901459A EP0173729B1 (de) 1984-03-14 1985-03-12 Verfahren zum lösen von wirksubstanzen und auf diese weise erhaltene arzneimittel

Publications (1)

Publication Number Publication Date
ATE57472T1 true ATE57472T1 (de) 1990-11-15

Family

ID=4206704

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85901459T ATE57472T1 (de) 1984-03-14 1985-03-12 Verfahren zum loesen von wirksubstanzen und auf diese weise erhaltene arzneimittel.

Country Status (12)

Country Link
US (1) US4794117A (de)
EP (1) EP0173729B1 (de)
JP (1) JPS61501566A (de)
KR (1) KR930000029B1 (de)
AT (1) ATE57472T1 (de)
AU (1) AU573321B2 (de)
DE (1) DE3580140D1 (de)
HU (1) HU195918B (de)
IT (1) IT1200410B (de)
NO (1) NO165626C (de)
OA (1) OA08170A (de)
WO (1) WO1985004106A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607662D0 (en) * 1986-03-27 1986-04-30 Rainsford K D Pharmaceutical formulation
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
US5110493A (en) * 1987-09-11 1992-05-05 Syntex (U.S.A.) Inc. Ophthalmic NSAID formulations containing a quaternary ammonium preservative and a nonionic surfactant
NO175404C (no) * 1987-09-11 1994-10-12 Syntex Inc Fremgangsmåte for fremstilling av et öyepreparat og konserveringsmiddelsystem for et slikt preparat
US5290774A (en) * 1989-08-03 1994-03-01 Eisai Co., Ltd. Photostabilizing method for ophthalmic solutions and the resulting ophthalmic solutions therefrom
EP0436726B1 (de) * 1989-08-03 1993-10-20 Eisai Co., Ltd. Verfahren zur photostabilisierung von augenspüllösungen
DE4342907A1 (de) * 1993-12-16 1995-06-22 Bayer Ag Neue cyclische Depsipeptide mit 18 Ringatomen und ihre Verwendung zur Bekämpfung von Endoparasiten
SK280278B6 (sk) * 1994-09-01 1999-10-08 Pharmacia + Upjohn Company Sterilná vodná farmaceutická kompozícia na parente
US6274592B1 (en) * 1997-02-04 2001-08-14 Senju Pharmaceutical Co., Ltd. Method for stabilizing arylcarboxylic acid, stabilizer thereof and aqueous solution containing stabilized arylcarboxylic acid
US6045815A (en) * 1997-08-15 2000-04-04 Board Of Regents, The University Of Texas System Parenteral pimaricin as treatment of systemic infections
US6844004B2 (en) * 1997-08-15 2005-01-18 Board Of Regents, The University Of Texas System Topical formulations of natamycin/pimaricin
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
US6387400B1 (en) 2000-08-29 2002-05-14 R.P. Scherer Technologies, Inc. Process for preparing pharmaceutical compositions for use with soft gelatin formulations
ITMI20012135A1 (it) 2001-10-16 2003-04-16 Bioren S A Soluzioni iniettabili pronte all'uso di paracetamolo
DE10161077A1 (de) * 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) * 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
FR2851164B1 (fr) 2003-02-14 2005-04-22 Xuan Tho Nguyen Formulation liquide injectable de paracetamol
EP1568369A1 (de) * 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam zur Behandlung von Atemwegserkrankungen bei Schweinen
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
EP1942902A1 (de) * 2005-09-30 2008-07-16 Boehringer Ingelheim Vetmedica Gmbh Meloxicam enthaltende pharmazeutische zubereitung
WO2009091622A1 (en) * 2008-01-18 2009-07-23 Dow Global Technologies Inc. Method to enhance aqueous solubility of poorly soluble actives using methoxypolyethylene glycol
CN102300552A (zh) 2009-02-03 2011-12-28 太阳星光齿磨公司 含有桔皮苷的组合物
PL4378443T3 (pl) 2009-10-12 2025-09-08 Boehringer Ingelheim Vetmedica Gmbh Pojemniki na kompozycje zawierające meloksykam
US20110218191A1 (en) * 2010-03-03 2011-09-08 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long term-treatment of kidney disorders in cats
CA2791805A1 (en) 2010-03-03 2011-09-09 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
MX2013000578A (es) * 2010-07-21 2013-02-21 Alcon Res Ltd Composicion farmaceutica con caracteristicas de solubilidad incrementadas.
GB201321743D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1916432A1 (de) * 1969-03-31 1970-10-08 Dresden Arzneimittel Verfahren zur Herstellung von Injektionsloesungen von therapeutisch wertvollen Benzodiazepinderivaten und ihren Kombinationen mit anderen Wirkstoffen
IL33774A0 (en) * 1970-01-26 1970-03-22 Abic Ltd A water-soluble composition comprising sulfadimidine and pyrimethamine
DK138974B (da) * 1974-02-19 1978-11-27 Ciba Geigy Ag Fremgangsmåde til fremstilling af vandige oxytetracyclinopløsninger til parenteral, peroral og lokal anvendelse.
DE3006024C2 (de) * 1980-02-18 1983-08-04 Solvon Arzneimittel-Vertriebs- Und Lizenzgesellschaft Mbh, 85011 Burgthann Topisches, Indomethacin enthaltendes Arzneimittel in Salbenform

Also Published As

Publication number Publication date
NO165626B (no) 1990-12-03
US4794117A (en) 1988-12-27
NO854461L (no) 1985-11-08
KR930000029B1 (ko) 1993-01-06
HUT38263A (en) 1986-05-28
DE3580140D1 (de) 1990-11-22
AU4064585A (en) 1985-10-11
IT1200410B (it) 1989-01-18
AU573321B2 (en) 1988-06-02
OA08170A (fr) 1987-03-31
IT8519873A0 (it) 1985-03-13
EP0173729B1 (de) 1990-10-17
EP0173729A1 (de) 1986-03-12
WO1985004106A1 (fr) 1985-09-26
HU195918B (en) 1988-08-29
KR850700216A (ko) 1985-12-26
NO165626C (no) 1991-03-13
JPS61501566A (ja) 1986-07-31

Similar Documents

Publication Publication Date Title
ATE57472T1 (de) Verfahren zum loesen von wirksubstanzen und auf diese weise erhaltene arzneimittel.
RU94027569A (ru) Органические соли n,n'-диацетилцистина, способ получения, фармацевтическая композиция, способы лечения
ATE87319T1 (de) Inklusionskomplexe von 7-isopropoxy-isoflavon mit cyclodextrinen, verfahren zu deren herstellung und diese inklusionskomplexe enthaltende pharmazeutische praeparate.
DK0580817T3 (da) Farmaceutisk præparat og fremgangsmåde til fremstilling deraf
DE68921760D1 (de) Behandlung von beschädigtem knochenmark und dosierungseinheiten dafür.
ES8602404A1 (es) Metodo de producir complejos solubles en agua de principios activos insolubles en agua y fosfolipidos
DE3789320D1 (de) Verabreichungsinstrument zum Einführen von festen Medikamenten.
ES2137948T3 (es) Sistema avanzado de administracion de medicamentos y metodo de tratamiento de trastornos psiquiatricos, neurologicos y otros con carbamacepina.
DE3681755D1 (de) Wirkstofftraeger und diesen enthaltende arzneimittel.
RU94040864A (ru) Конденсированные индольные производные, их получение, фармацевтическая композиция
MA26435A1 (fr) Derives de benzylamine amido-substitues, leurs derives precurseurs de medicaments, leur procede de preparation, compositions pharmaceutiques les contenant et methode de traitement les utilisant.
RU94046093A (ru) Производные 7-(2-аминоэтил)бензотиазолона, способ их получения, промежуточные соединения, фармкомпозиция
PL301582A1 (en) Substituted derivatives 4-phenyl-pyridonyl and 4-phenyl-2-alkoxy pyridine, method of obtaining such derivative and therapeutical agents containing them
DE3864348D1 (de) Mikropartikel, bestehend aus einem biodegradierbaren, die freisetzung eines antimalaria-wirkstoffs kontrollierenden polymer, diese enthaltende pharmazeutische zusammensetzungen und ihr herstellungsverfahren.
DE58901002D1 (de) Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken.
EP0590460A3 (de) Hochkonzentrierte wässrige Poly(acrylnitril)-Emulsionen und Verfahren zu ihrer Herstellung.
KR880009018A (ko) 3-l-피로글루타밀-l-티아졸리딘-4-카르복실산 및 이의 제법
IT7924769A0 (it) Derivati di acidi aziridin-2-carbossilici n-sostituiti con attivita'immunostimolante, processi per laloro preparazione e farmaci contenenti tali sostanze.
RU93058533A (ru) Производные аминокислот, стенокардическое средство и способ получения производных аминокислот
IT7827078A0 (it) Derivati di acidi 2-idrazono propionici n-sostituti, processi per la loro preparazione e farmaci che contengono tali sostanze.
OA09794A (fr) Dérivés de pyridone amino acide azetidinyl substitués, leur préparation et leur application en tant que médicaments.
RU95112241A (ru) Способ коррекции побочных эффектов химиолучевой терапии
RU2014082C1 (ru) Противоопухолевое средство
FR2676648B1 (fr) Nouvelles compositions, leur procede de preparation et leurs applications comme substance active de medicament antigrippal ou antiviral.
HU886315D0 (en) Process for the production of pharmaceutical preparations for curing hyperlipaemia, containing oxoquinazoline derivatives as active agents